| Issue |
Title |
| Vol 6, No 4 (2014) |
Specific Visualization of Tumor Cells Using Upconversion Nanophosphors |
|
|
Grebenik E.A., Generalova A.N., Nechaev A.V., Khaydukov E.V., Mironova K.E., Stremovskiy O.A., Lebedenko E.N., Zvyagin A.V., Deyev S.M. |
| Vol 10, No 4 (2018) |
The Mechanism of Fluorescence Quenching of Protein Photosensitizers Based on miniSOG During Internalization of the HER2 Receptor |
|
|
Kuzichkina E.O., Shilova O.N., Deyev S.M. |
| Vol 10, No 3 (2018) |
A Novel Approach to Anticancer Therapy: Molecular Modules Based on the Barnase:Barstar Pair for Targeted Delivery of HSP70 to Tumor Cells |
|
|
Sapozhnikov A.M., Klinkova A.V., Shustova O.A., Grechikhina M.V., Kilyachus M.S., Stremovskiy O.A., Kovalenko E.I., Deyev S.M. |
| Vol 7, No 3 (2015) |
Apigenin Inhibits Growth of Breast Cancer Cells: The Role of ERα and HER2/neu |
|
|
Scherbakov A.M., Andreeva O.E. |
| Vol 7, No 3 (2015) |
Internalization and Recycling of the HER2 Receptor on Human Breast Adenocarcinoma Cells Treated with Targeted Phototoxic Protein DARPinminiSOG |
|
|
Shilova O.N., Proshkina G.M., Lebedenko E.N., Deyev S.M. |
| Vol 7, No 4 (2015) |
Recombinant Immunotoxin 4D5scFv-PE40 for Targeted Therapy of HER2-Positive Tumors |
|
|
Sokolova E.A., Stremovskiy O.A., Zdobnova T.A., Balalaeva I.V., Deyev S.M. |
| Vol 9, No 1 (2017) |
Spheroids of HER2-Positive Breast Adenocarcinoma for Studying Anticancer Immunotoxins In Vitro |
|
|
Balalaeva I.V., Sokolova E.A., Puzhikhina A.D., Brilkina A.A., Deyev S.M. |
| Vol 9, No 3 (2017) |
The Effect of the Targeted Recombinant Toxin DARPin-PE40 on the Dynamics of HER2-Positive Tumor Growth |
|
|
Sokolova E.A., Proshkina G.M., Kutova O.M., Balalaeva I.V., Deyev S.M. |
| Vol 3, No 3 (2011) |
Silencing of Her2, CCNB1 and pKC Genes by siRNA Results in Prolonged Retardation of Neuroblastoma Cell Division |
|
|
Akimov I.A., Chernolovskaya E.L., Spitsyna Y.E., Ryabchikova E.I., Zenkova M.A. |
| 1 - 9 of 9 Items |
|
